Ann Varanakis - 08 Mar 2024 Form 4 Insider Report for LifeStance Health Group, Inc. (LFST)

Role
Chief People Officer
Signature
By: /s/ Ryan Pardo, Attorney-in-Fact
Issuer symbol
LFST
Transactions as of
08 Mar 2024
Net transactions value
-$106,958
Form type
4
Filing time
12 Mar 2024, 21:48:09 UTC
Previous filing
25 Aug 2023
Next filing
27 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFST Common Stock Award $0 +83,217 +49% $0.000000 251,658 08 Mar 2024 Direct F1
transaction LFST Common Stock Award $0 +32,052 +13% $0.000000 283,710 08 Mar 2024 Direct F2
transaction LFST Common Stock Sale $106,958 -15,434 -5.4% $6.93 268,276 11 Mar 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 83,217 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 Represents performance-based restricted stock units previously granted to the Reporting Person, which vested on March 8, 2024.
F3 Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.